SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Brain Cell Re-growth Demonstrated By Canadian Scientists University of Lethbridge Study
August 2, 2010
 · 
1 min read
Drug Development
Key Step in Body’s Ability to Make Red Blood Cells Discovered, UT Southwestern Medical Center Study
August 2, 2010
 · 
1 min read
Drug Development
Epileptic Seizures May Be Linked To An Ancient Gene Family, Penn State University and Baylor College of Medicine Study
August 2, 2010
 · 
1 min read
Drug Development
Cell-of-Origin for Human Prostate Cancer Identified for First Time, University of California, Los Angeles (UCLA) Study
July 30, 2010
 · 
1 min read
Drug Development
‘Sleep Control’ Cells Allow Blind Mice To See, Johns Hopkins University Study
July 26, 2010
 · 
1 min read
Drug Development
Gene Curtails Alzheimer’s In Mice, Massachusetts Institute of Technology (MIT) Study
July 23, 2010
 · 
1 min read
Drug Development
Stem Cells for Eating and Sex Pinpointed, GW Institute for Neuroscience Study
July 22, 2010
 · 
1 min read
Drug Development
Unearthing King Tet: Key Protein Influences Stem Cell Fate, University of North Carolina Study
July 19, 2010
 · 
1 min read
Drug Development
Redundant Genetic Instructions in ‘Junk DNA’ Support Healthy Development, Princeton University
July 19, 2010
 · 
1 min read
Drug Development
Vaccine-Delivery Patch With Dissolving Microneedles Eliminates ‘Sharps,’ Boosts Protection, Emory University And Georgia Institute of Technology Study
July 19, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
SELLAS Life Sciences’ Highly Selective CDK9 Inhibitor, GFH009, Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Model of Neuroendocrine Prostate Cancer Cell Line
August 24, 2022
 · 
5 min read
Drug Development
Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
August 24, 2022
 · 
5 min read
Drug Development
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
August 24, 2022
 · 
4 min read
Drug Development
VectorY to Present Poster on Huntington’s Preclinical Data at the Hereditary Disease Foundation, August 24-27 in Cambridge, MA
August 23, 2022
 · 
3 min read
Drug Development
Translational Research Describes an Epigenetic Approach for Regulating Fear-Memory
August 22, 2022
 · 
6 min read
Drug Development
L2P Research® Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S.
August 19, 2022
 · 
1 min read
Drug Development
Artelo Biosciences Reports Positive Pre-Clinical Results with its Novel Inhibitor to Fatty Acid Binding Protein 5Recently Published Findings Support Further Development in Anxiety-Related Disorders
August 16, 2022
 · 
4 min read
Drug Development
Nektar and Collaborators Announce Preclinical Publication of Data for NKTR-255 and its Observed Improvement of NK Cell Function in Multiple Myeloma
August 16, 2022
 · 
7 min read
Drug Development
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI ‘JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC)
August 16, 2022
 · 
2 min read
Drug Development
Crestone, Inc. and Praedicare Inc. Announce the Publication of Data on the Novel Antibiotic CRS0540 in the Hollow Fiber System Model of the Orphan Disease Disseminated Listeriosis
August 15, 2022
 · 
4 min read
Drug Development
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis
August 11, 2022
 · 
5 min read
Drug Development
Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections
August 10, 2022
 · 
6 min read
Drug Development
SELLAS Life Sciences’ GFH009 Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Studies in Solid Cancer and Acute Myeloid Leukemia Cell Lines
August 9, 2022
 · 
6 min read
Drug Development
CalciMedica Announces Publication of Preclinical Data in EMBO Molecular Medicine Supporting the Development of CRAC Channel Inhibitors for Inflammatory Bowel Disease (IBD)
August 9, 2022
 · 
5 min read
Drug Development
Fate Therapeutics Announces Preclinical Publication Highlighting Derivation of CD8αβ T Cells from TCR-CAR+ Induced Pluripotent Stem Cells
August 9, 2022
 · 
10 min read
Drug Development
Panavance Therapeutics Announces Publication of Promising Preclinical Data Evaluating GP-2250 for the Treatment of Malignant Peritoneal Mesothelioma
August 8, 2022
 · 
5 min read
Drug Development
Athersys Announces Favorable Preclinical Results for MultiStem® Treatment in Defense Department Radiation Countermeasure Study and Upcoming Webinar to Review Preclinical Research With MultiStem Across Multiple Indications
August 8, 2022
 · 
9 min read
Drug Development
PNAS Published Preclinical Results of Harbour BioMed’s Next-Generation Fully Human Heavy-chain Antibody Porustobart
August 8, 2022
 · 
3 min read
Drug Development
Nuvalent Presents New Preclinical Data Supporting Potential Best-in-Class Profile for ALK-Selective Inhibitor NVL-655 at IASLC 2022 World Conference on Lung Cancer Annual Meeting
August 5, 2022
 · 
12 min read
Business
Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
August 4, 2022
 · 
9 min read
Load More